Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
40 participants
INTERVENTIONAL
2024-03-01
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Anti-aging Efficacy of Two Dietary Supplements
NCT06032598
Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging
NCT03460860
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
NCT05300984
Biological Anti-aging Efficacy of a Cosmetic Night Cream
NCT06433323
Evaluation of the Effectiveness of the Anti-aging Effect of a Supplement in Improving Skin Conditions
NCT05879289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
skin aging patients
gayo arabica coffee skin extract cream
Assessment of glagou scale, skin analyzer, corneometer, and tewameter was done before and after the treatment . The subject will receive directions on how to use the cream before the study starts. The cream was used 2 times daily (7.40 AM and 1.00 PM) for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
gayo arabica coffee skin extract cream
Assessment of glagou scale, skin analyzer, corneometer, and tewameter was done before and after the treatment . The subject will receive directions on how to use the cream before the study starts. The cream was used 2 times daily (7.40 AM and 1.00 PM) for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have skin aging condition aged 30-60 years.
* Willing to participate in research based on research protocols.
* Before the research begins, research subjects are willing to sign informed consent and participate in the research until completion according to the research provisions from initial examination, re-control, and treatment until completion).
Exclusion Criteria
* have a skin disorder and are undergoing treatment for skin disease.
* Undergoing treatment and use of facial cream in the last 1 month.
* History of allergy to coffee.
30 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wahyu Lestari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wahyu Lestari
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wahyu Lestari, MD
Role: PRINCIPAL_INVESTIGATOR
Department of dermatology, venereology, and aesthetic dr. Zainoel Abidin General Hospital Banda Aceh, Nanggroe Aceh Darussalam, Indonesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
dr. Zainoel Abidin General Hospital
Banda Aceh, Special Region of Aceh, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Esquivel P, Jiménez VM. Functional Properties of Coffee and Coffee By-products. Food Res Int. 2012;5(3):1-9. doi:10.1016/j.foodres.2011.05.028
Murthy PS, Madhava Naidu M. Sustainable Management of Coffee Industry By-products and Value Addition - A review. Resour Conserv Recycl. Published online 2012:1-10. doi:10.1016/j.resconrec.2012.06.005
Sholichah E, Apriani R, Desnilasari D, Karim MA. Produk Samping Kulit Kopi Arabika dan Robusta Sebagai Sumber Polifenol Untuk Antioksidan dan Antibakteri. Balai Besar Ind Has Perkeb. Published online 2019:57-66.
Iriondo-DeHond A, Elizondo AS, Iriondo-DeHond M, Rios MB, Mufari R, Mendiola JA, Ibanez E, Castillo MDD. Assessment of Healthy and Harmful Maillard Reaction Products in a Novel Coffee Cascara Beverage: Melanoidins and Acrylamide. Foods. 2020 May 12;9(5):620. doi: 10.3390/foods9050620.
Ameca GM, Cerrilla MEO, Córdoba PZ, Cruz AD, Hernández MS, Haro JH. Chemical Composition and Antioxidant Capacity of Coffee Pulp. Cienc e Agrotecnologia. 2018;4(3):307-313. doi:10.1590/1413-70542018423000818
Klingel T, Kremer JI, Gottstein V, Rajcic de Rezende T, Schwarz S, Lachenmeier DW. A Review of Coffee By-Products Including Leaf, Flower, Cherry, Husk, Silver Skin, and Spent Grounds as Novel Foods within the European Union. Foods. 2020 May 21;9(5):665. doi: 10.3390/foods9050665.
Tuong W, Walker L, Sivamani RK. Polyphenols as novel treatment options for dermatological diseases: A systematic review of clinical trials. J Dermatolog Treat. 2015;26(4):381-8. doi: 10.3109/09546634.2014.991675. Epub 2014 Dec 30.
Islam MT, Tabrez S, Jabir NR, Ali M, Kamal MA, da Silva Araujo L, De Oliveira Santos JV, Da Mata AMOF, De Aguiar RPS, de Carvalho Melo Cavalcante AA. An Insight into the Therapeutic Potential of Major Coffee Components. Curr Drug Metab. 2018;19(6):544-556. doi: 10.2174/1389200219666180302154551.
Petruk G, Del Giudice R, Rigano MM, Monti DM. Antioxidants from Plants Protect against Skin Photoaging. Oxid Med Cell Longev. 2018 Aug 2;2018:1454936. doi: 10.1155/2018/1454936. eCollection 2018.
Bosch R, Philips N, Suarez-Perez JA, Juarranz A, Devmurari A, Chalensouk-Khaosaat J, Gonzalez S. Mechanisms of Photoaging and Cutaneous Photocarcinogenesis, and Photoprotective Strategies with Phytochemicals. Antioxidants (Basel). 2015 Mar 26;4(2):248-68. doi: 10.3390/antiox4020248.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
094/ETIK-RSUDZA/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.